Astec Lifesciences consolidated net profit rises 101.87% in the September 2022 quarter
Sales rise 94.75% to Rs 199.75 crore
Net profit of Astec Lifesciences rose 101.87% to Rs 18.31 crore in the quarter ended September 2022 as against Rs 9.07 crore during the previous quarter ended September 2021. Sales rose 94.75% to Rs 199.75 crore in the quarter ended September 2022 as against Rs 102.57 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales199.75102.57 95 OPM %16.6620.55 -PBDT32.7520.33 61 PBT24.5812.18 102 NP18.319.07 102Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 28 2022 | 5:30 PM IST